Symbol="IMCR"
AssetType="Common Stock"
Name="Immunocore Holdings Ltd"
Description="Immunocore Holdings Limited, an advanced stage biotechnology company, develops immunotherapies for the treatment of cancer, infectious and autoimmune diseases. The company is headquartered in Abingdon, the United Kingdom."
CIK="1671927"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="90 PARK DRIVE, MILTON PARK, ABINGDON, OXFORDSHIRE, GB"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="2816082000"
EBITDA="-45729000"
PERatio="None"
PEGRatio="None"
BookValue="5.67"
DividendPerShare="0"
DividendYield="0"
EPS="-1.27"
RevenuePerShareTTM="3.784"
ProfitMargin="-0.274"
OperatingMarginTTM="-0.272"
ReturnOnAssetsTTM="-0.0838"
ReturnOnEquityTTM="-0.225"
RevenueTTM="181566000"
GrossProfitTTM="54113000"
DilutedEPSTTM="-1.27"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.493"
AnalystTargetPrice="80.92"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="27.83"
PriceToBookRatio="8.13"
EVToRevenue="25.36"
EVToEBITDA="-54.19"
Beta="0.624"
num_52WeekHigh="69.06"
num_52WeekLow="38.9"
num_50DayMovingAverage="61.67"
num_200DayMovingAverage="58.39"
SharesOutstanding="48941300"
DividendDate="None"
ExDividendDate="None"
symbol="IMCR"
open="58.10"
high="58.47"
low="57.02"
price="57.54"
volume="305612.00"
latest_trading_day="2023-08-25"
previous_close="57.94"
change="-0.40"
change_percent="-0.6904%"
aroon_positive_momentum_days="71"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="71"
Volume_recent_avg="229434"
Change_recent_avg="0.15"
Delta_recent_avg="2.36"
Variance_recent_avg="1.18"
Change_ratio_recent_avg="0.24"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="71"
Aroon_momentum_negative="29"
image_negative_thumbnail_id_1="1135"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0168.jpeg"
image_negative_thumbnail_id_2="488"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0117.jpeg"
image_neutral_thumbnail_id_1="542"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0057.jpeg"
image_neutral_thumbnail_id_2="588"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0011.jpeg"
image_positive_thumbnail_id_1="954"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0116.jpeg"
image_positive_thumbnail_id_2="621"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0087.jpeg"
image_professor_thumbnail_id_1="1198"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0032.jpeg"
image_professor_thumbnail_id_2="1195"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0029.jpeg"
